Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

237 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Protein therapeutics--lessons learned and a view of the future.
Johnson-Léger C, Power CA, Shomade G, Shaw JP, Proudfoot AE. Johnson-Léger C, et al. Among authors: proudfoot ae. Expert Opin Biol Ther. 2006 Jan;6(1):1-7. doi: 10.1517/14712598.6.1.1. Expert Opin Biol Ther. 2006. PMID: 16370909 Review.
Strategies for chemokine antagonists as therapeutics.
Proudfoot AE, Power CA, Rommel C, Wells TN. Proudfoot AE, et al. Semin Immunol. 2003 Feb;15(1):57-65. doi: 10.1016/s1044-5323(02)00128-8. Semin Immunol. 2003. PMID: 12495641 Review.
Chemokine blockers--therapeutics in the making?
Wells TN, Power CA, Shaw JP, Proudfoot AE. Wells TN, et al. Among authors: proudfoot ae. Trends Pharmacol Sci. 2006 Jan;27(1):41-7. doi: 10.1016/j.tips.2005.11.001. Epub 2005 Nov 28. Trends Pharmacol Sci. 2006. PMID: 16310864 Review.
Anti-chemokine small molecule drugs: a promising future?
Proudfoot AE, Power CA, Schwarz MK. Proudfoot AE, et al. Expert Opin Investig Drugs. 2010 Mar;19(3):345-55. doi: 10.1517/13543780903535867. Expert Opin Investig Drugs. 2010. PMID: 20113217 Review.
237 results